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†University of Groningen, Department of Drug Design, A. Deusinglaan 1, 9713 AV Groningen, The Netherlands
‡Jagiellonian University, Faculty of Chemistry, Gronostajowa 2, 30-387 Krakow, Poland
*S Supporting Information
ABSTRACT: The synthesis of uracil/thymine containing
tetra/trisubstituted imidazole derivatives was demonstrated
using Ugi/Passerini-reaction followed by a postcyclization
reaction sequence. The approach enables the one-pot facile
construction of diverse compounds in moderate to excellent
yields (47−82%). The 5-ﬂuorouracil and 5-methyluracil
moieties aﬀord potentially bioactive molecules with drug-like properties. These scaﬀolds are currently being utilized in the
screening deck of the European Lead Factory.
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Uracil (U), thymine (T), and their corresponding derivativesare highly important fragments in bioactive molecules
including drugs and cofactors, for example, 5-ﬂuorouracil and 5-
mercaptouracil which are important anticancer agents.1 In the
protein databank there are multiple examples of U and T binding
in a highly speciﬁc way to diﬀerent receptors.2 The CO−NH−
COmoiety of T and U binds exclusively, employing all hydrogen
bond donor and acceptor atoms (Figure 1). Additionally, the U/
T binding site in receptors is mostly very narrow, accommodat-
ing the ﬂat six-membered ring tightly and deeply buried. Thus,
the heterocyclic U/T comprise a strong anchoring motif and can
be used as starting point for the design of U/T mimics which can
potentially alter the biological activity of the receptor. Such
anchoring motifs (hydrophobic amino acids in protein interface
epitopes) have already been successfully used for the design of
potent protein−protein interaction small molecular weight
antagonists.3 To leverage nucleobase anchors in drug discovery,
fast and eﬃcient access to organic non-nucleotide derivatives is
essential and currently not given.
Therefore, we propose here the usage of privileged nucleobase
building blocks derived from U and T in multicomponent
reactions to synthesize nucleobase derivatives in a highly general
and eﬃcient way. As a ﬁrst example, we are grafting the
nucleobases U and T onto ﬂat heterocyclic ﬁve-membered
oxazole and imidazole heterocycles connected by a methylene
moiety to allow for suﬃcient conformational ﬂexibility and drug-
like properties. The vast majority of the synthetic routes toward
imidazole synthesis focuses on the synthesis of disubstituted
imidazole rings.4,5 The van Leusen three component imidazole
synthesis (vL-3CR) is a common and convenient synthetic
strategy; however, is limited to tosylmethyl isocyanide
(TosMIC) or its derivatives.6 In recent years there has been a
tremendous development in literature for disubstituted
imidazoles via multistep ring closing methods which are limited
in scope and require harsh conditions.4 However, synthesizing
tri- and tetra-substituted imidazoles having a speciﬁc substitution
pattern can be challenging. Importantly, uracil containing, tetra-
substituted imidazoles are particularly diﬃcult to obtain. In this
context, multi component reactions (MCRs) are recognized as
valuable tools to decorate the complex molecules in short and
mild process.7 Practically isocyanide based multicomponent
reactions (IMCRs) (Ugi and Passerini) are highly convergent
processes which have a great impact in pharmaceutical and drug
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Figure 1. Thymine and uracil are important anchoring moieties toward
protein receptors displaying a distinct universal hydrogen bonding
network. Above: schematic hydrogen bonding network of U derivatives
with hydrogen bond donors and acceptors shown as blue and red dotted
lines, respectively. Below: Mycobacterium tuberculosis dUTPase com-
plexed with dUTP (PDB ID 1SMC) as an archetypical nucleobase
receptor interaction.
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discovery research.8 Hence, the synthesis of imidazole scaﬀold by
Ugi- and Passerini-reactions could be an interesting subject to
study and explore through IMCRs.
Initially, the Ugi four-component reaction (U-4CR) of
phenylglyoxal 1{1}, 3,4-dimethoxyphenethylamine 2{1}, cyclo-
hexyl isocyanide 3{1}, and uracil derived acetic acid 4{1} in
methanol (1.0 M) furnished the corresponding product in poor
yields even after 48 h. After a thorough investigation, it was found
that a mixture of DCM/DMF (1:1) was the appropriate
combination for this Ugi-reaction to yield up to 90% within 48
h. After completion of the Ugi reaction, we aimed to convert the
Ugi products to the corresponding tetra-substituted imidazoles
using an excess of NH4OAc (15 equiv) in acetic acid at 120 °C for
1 h, which aﬀorded the desired product in 75% yield. Next, we
investigated the U-4CR and the postcyclization reaction in a one
pot-sequence. The optimized conditions can be described as, the
use of 1.0 equiv of isocyanide 3{1} relative to the aldehyde 1{1}
(1.0 mmol), amine 2{1} (1.0 mmol), and 4{1} (1.0 mmol) in
DCM:DMF (1:1) at 25 °C for 48 h. After quick ﬁltration and
evaporation of the solvents, the resulting crude material was
treated with NH4OAc (15 equiv) in AcOH at 120 °C for 1 h
furnishing the desired product 6{1,1,1,1} in 60% overall yield.
All isocyanides aﬀorded the corresponding imidazoles in good
yields (Table 1). Interestingly, even the bulky adamantine 3{10}
and camphor 3{9} derived isocyanides reacted nicely. TheU4CR
and post cyclization reaction worked with all aliphatic and
aliphatic-aromatic amines resulting in a variety of tetra-
substituted imidazoles in good to excellent overall yields
(Table 1). Products 6{1,1,8,3} (57%) and 6{1,1,8,2} (47%)
obtained from 5-ﬂuorouracil and 5-methyluracil acetic acids
respectively are interesting analogs of the marketed drugs
Retrovir and Tegafur obtained in just two synthetic steps. Both
tri- and tetra-substituted imidazole libraries reported within the
paper have average values of Molecular Weight (MW), logP,
Hydrogen Bond Donors (HBD) and Hydrogen Bond Acceptors
(HBA) that follow the Lipinski rule of 5 suggesting a possible
drug likeness that can be further explored (see SI).
After the successful synthesis of the tetra-substituted
imidazoles, we planned to synthesize oxazoles by employing
the Passerini reaction as an initial step. The above optimized
reaction conditions were used in the Passerini reaction as well
followed by the cyclization reaction sequence. Phenylglyoxal,
cyclohexyl isocyanide and uracil derived acetic acid were reacted
in DCM:DMF (1:1) for 48 h. The crude mixtures were treated
with NH4OAc (15 equiv) in AcOH at 120 °C for 1 h.
After careful elucidation of the X-ray structures of compounds
8{1,9,1} and 8{1,11,1}, we concluded that the free NH-
imidazole was formed instead of the expected trisubstituted
oxazole. The formation of the imidazole instead of the oxazole
can be attributed to the excess of ammonia used during the
reaction. A proposed mechanism involves the initial formation of
the oxazole followed by the nucleophilic attack of ammonia at the
C2. Subsequently the oxazole ring opens through the
intermediacy of an amidine at C-2 and a ketone at C-5 followed
by dehydration which leads to the unexpected free NH-imidazole
(Scheme 1). The postcyclization step of the Passerini products
was also performed with 1.0 equiv of NH4OAc in AcOH at 120
°C, but still the formation of imidazole along with oxazole (22%
and 16% yield respectively) and incomplete starting material was
observed, even after 12 h of reaction time. With these results in
hand, we decided to investigate the synthesis of a library of NH-
imidazoles.
The structures exhibit interesting hydrogen bonding patterns.
In 8{1,9,1}, the Uracil undergoes a bifurcated hydrogen bonding
to the Uracil of a neighboring molecule. Moreover, a hydrogen
bond from the imidazole NH to a DMSO solvent molecule is
formed. In 8{1,11,1}, a hydrogen bonding between the imidazole
NH to the U-CO of a neighboring molecule is formed.
In general, the free NH-imidazoles were obtained in good
yields regardless of their steric and electronic properties. First, a
wide variety of aliphatic and aliphatic-aromatic isocyanides were
reacted with phenylglyoxal 1{1} and uracil derived acetic acid in
Figure 2. Chemset 1 consisting of phenyl glyoxal.
Figure 3. Chemset 2 consisting of amines.
Figure 4. Chemset 3 consisting of isocyanides.
Figure 5. Chemset 4 consisting of acids.
ACS Combinatorial Science Letter
DOI: 10.1021/acscombsci.7b00145
ACS Comb. Sci. 2018, 20, 192−196
193
DCM:DMF (1:1) followed by an excess of NH4OAc (15 equiv)
and treatment in acetic acid at 120 °C for 1 h, providing the
desired free NH-imidazoles 8 in very good yield. On the other
hand, indole and amino acid derived isocyanides were also valid
substrates in the Passerini/cyclization sequence (8{1,12,1} and
8{1,13,1}). 5-Fluoro and 5-methyl uracil acetic acids along with
phenylglyoxal and isocyanides also furnished the expected
trisubstituted imidazoles (8{1,1,3}, 8{1,8,3}, and 8{1,8,2}) in
47%, 57%, and 63% yields, respectively.
Imidazole rings are the second most common ﬁve-membered
aromatic nitrogen heterocycles U.S. FDA approved drugs.9a The
imidazole ring is considered to be an attractive isostere of a
triazole, oxazole, pyrazole, thiazole, and tetrazole because of its
capability to coordinate with a variety of inorganic metal ions, as
well as biological molecules in the human body. In this report,
along with the imidazole ring, we have grafted an attractive extra
uracil part and based on the interesting scaﬀold properties they
are now part of the screening decks of the European Lead Factory
(ELF).9b In summary, we have described a novel method for the
synthesis of Uracil containing tetra- and trisubstituted
imidazoles. This simple and mild procedure is a valuable
addition to MCR chemistry and expands its unique scaﬀold
diversity. Work is ongoing to identify biological targets for our
compound libraries and will be reported in due course.
■ EXPERIMENTAL PROCEDURES
Nuclear magnetic resonance spectra were recorded on a Bruker
Avance 500 spectrometer {1HNMR (500MHz), 13C NMR (126
MHz)}. Chemical shifts for 1H NMR were reported as δ values
and coupling constants were in hertz (Hz). The following
abbreviations were used for spin multiplicity: s = singlet, br s =
broad singlet, d = doublet, t = triplet, q = quartet, quin = quintet,
dd = double of doublets, ddd = double of doublet of doublets, m
= multiplet. Chemical shifts for 13C NMR were reported in ppm
relative to the solvent peak. Thin layer chromatography was
performed on Fluka precoated silica gel plates (0.20 mm thick,
particle size 25 μm). Flash chromatography was performed on a
Teledyne ISCO Combiﬂash Rf, using RediSep Rf Normal-phase
Silica Flash Columns (Silica Gel 60 Å, 230−400 mesh) and on a
Reveleris X2 Flash Chromatography, using Grace Reveleris Silica
ﬂash cartridges (12 g). Reagents were available from commercial
suppliers (Sigma-Aldrich, ABCR, Acros, and AK Scientiﬁc) and
used without any puriﬁcation unless otherwise noted. All
microwave irradiation reactions were carried out in a Biotage
Initiator Microwave Synthesizer. Electrospray ionization mass
Table 1. Synthesis of Tetra-Substituted Imidazoles 6a,b
aReactions were carried out in DCM:DMF (1:1) (0.5 M) with 1.0
equiv of 3 relative to the aldehyde 1 (1.0 mmol), amine 2 (1.0 mmol),
and acid 4 (1.0 mmol) at 25 °C for 24−48 h. After a simple ﬁltration,
resulting crude mixture was treated with NH4OAc (15 equiv) in
AcOH (0.5 M) at 120 °C for 1 h. bYield refers to the puriﬁed
products.
Table 2. Synthesis of Tri-Substituted NH-Imidazoles 8a,b
aReactions were carried out in DCM:DMF (1:1) (0.5 M) with 1.0
equiv of 3 relative to the aldehyde 1 (1.0 mmol) and isocyanide 3 (1.0
mmol) at 25 °C for 24−48 h. After one quick ﬁltration, resulting crude
products were treated with NH4OAc (15 equiv) in AcOH (0.5 M) at
120 °C for 1 h. bYield refers to the column-puriﬁed products.
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spectra (ESI-MS) were recorded on a Waters Investigator
Semiprep 15 SFC-MS instrument.
Typical Procedures for the Synthesis of Compounds 6
and 8. Procedure A. General procedure for the synthesis of
imidazole derivatives 6: In an ordinary glass vial equipped with a
magnetic stirring bar, to a mixture of DCM:DMF (1:1) (0.5 M)
were added amine (1.0 mmol) and 2-oxo-2-phenylacetaldehyde
(1.0 mmol). After stirring for a minute, were added isocyanide
(1.0 mmol) and acid (1.0 mmol). The reaction mixture was
stirred at 25 °C for 24 to 48 h. The crude mixture was ﬁltered
through a pad of silica eluting with DCM:MeOH (9:1).
Resulting mixture was treated with NH4OAc (15 equiv) in
AcOH (0.5 M) at 120 °C for 1 h. The crude reaction mixture was
worked up with saturated NaHCO3 solution and the aqueous
layer was extracted with dichloromethane (3 × 10 mL). The
combined organic layers were dried (Na2SO4), ﬁltered and
concentrated. Pure products were obtained through column
chromatography (silica gel, mixture of DCM/MeOH).
Procedure B. General procedure for the synthesis of free NH-
imidazole derivatives 8: In an ordinary glass vial equipped with a
magnetic stirring bar, to a mixture of DCM:DMF (1:1) (0.5 M)
were added 2-oxo-2-phenylacetaldehyde (1.0 mmol) isocyanide
(1.0 mmol) and acid (1.0 mmol). The reaction mixture was
stirred at 25 °C for 24 to 48 h. The crude mixture was ﬁltered
through a pad of silica eluting with DCM:MeOH (9:1),
evaporated to dry and resulting mixture was treated with
NH4OAc (15 equiv) in AcOH (0.5 M) at 120 °C for 1 h. The
crude reaction mixture was worked up with saturated NaHCO3
solution and the aqueous layer was extracted with dichloro-
methane (3 × 10 mL). The combined organic layers were dried
(Na2SO4), ﬁltered and concentrated. Pure products were
obtained through column chromatography (silica gel, mixture
of DCM/MeOH).
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